NCT00326807View on ClinicalTrials.gov

Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

June 30, 2004

Conditions
Concurrent Alcohol Dependence and Pathological Gambling
Interventions
DRUG

Naltrexone

Trial Locations (2)

M5S 2S1

Centre for Addiction and Mental Health, Toronto

FIN-00101

National Public Health Institute, Helsinki

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT00326807 - Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling | Biotech Hunter | Biotech Hunter